IL71017A - Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha - Google Patents

Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha

Info

Publication number
IL71017A
IL71017A IL71017A IL7101784A IL71017A IL 71017 A IL71017 A IL 71017A IL 71017 A IL71017 A IL 71017A IL 7101784 A IL7101784 A IL 7101784A IL 71017 A IL71017 A IL 71017A
Authority
IL
Israel
Prior art keywords
diagnosis
purification
detection
cell lines
monoclonal antibodies
Prior art date
Application number
IL71017A
Other languages
English (en)
Other versions
IL71017A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL71017A0 publication Critical patent/IL71017A0/xx
Publication of IL71017A publication Critical patent/IL71017A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL71017A 1983-02-22 1984-02-21 Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha IL71017A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306060 DE3306060A1 (de) 1983-02-22 1983-02-22 Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IL71017A0 IL71017A0 (en) 1984-05-31
IL71017A true IL71017A (en) 1987-12-31

Family

ID=6191474

Family Applications (1)

Application Number Title Priority Date Filing Date
IL71017A IL71017A (en) 1983-02-22 1984-02-21 Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha

Country Status (7)

Country Link
EP (1) EP0119476A3 (da)
JP (1) JPS59224687A (da)
DE (1) DE3306060A1 (da)
DK (1) DK85084A (da)
ES (2) ES529912A0 (da)
FI (1) FI840675L (da)
IL (1) IL71017A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
GB8615353D0 (en) * 1986-06-24 1986-07-30 Antibioticos Sa Interferon
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
SE468251B (sv) 1989-06-20 1992-11-30 Bionative Ab Reningsprocess foer interferon
FI930058A0 (fi) * 1990-07-10 1993-01-08 Boehringer Ingelheim Int O-glykolyserad alfa-ifn
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
CA2670594A1 (en) 2006-12-06 2008-06-12 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
AU2008247398B2 (en) 2007-05-03 2013-10-10 Medimmune, Llc Interferon alpha-induced pharmacodynamic markers
NZ585064A (en) 2007-11-05 2012-08-31 Medimmune Llc Methods of treating scleroderma
BRPI0908065A2 (pt) 2008-02-08 2015-08-11 Medimmune Llc Métodos para tratar um paciente que possui um ifn do tipo i ou doença ou distúrbio mediado por ifnalfa, para neutralizar um perfil de marcador mirna diferencialmente regulado em um paciente, para monitorar ou prognosticar uma progressão da doença inflamatória e da doença miosite de um paciente, para monitorar a progressão da doença inflamatória ou autoimune e da doença miosite de um paciente e para tratar um paciente com miosite
SMT201700063T1 (it) 2009-09-03 2017-03-08 Medimmune Llc Diagnosi di interferoni di tipo 1
EP3924383A1 (en) 2019-02-15 2021-12-22 Astrazeneca AB Type i interferon-mediated disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
DE3177276D1 (de) * 1980-04-11 1992-04-23 Celltech Ltd Monoklonale antikoerper.
FR2500754B1 (fr) * 1981-02-27 1986-06-27 Hoffmann La Roche Anticorps monoclonaux
EP0139676B1 (en) * 1983-02-04 1992-11-25 Cytoclonal Pharmaceutics Inc. Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
GB8303165D0 (en) * 1983-02-04 1983-03-09 Secher D S Monoclonal antibody

Also Published As

Publication number Publication date
EP0119476A2 (de) 1984-09-26
FI840675A7 (fi) 1984-08-23
FI840675L (fi) 1984-08-23
DK85084D0 (da) 1984-02-21
FI840675A0 (fi) 1984-02-20
DK85084A (da) 1984-08-23
ES535509A0 (es) 1985-05-16
IL71017A0 (en) 1984-05-31
EP0119476A3 (de) 1987-04-08
ES8503371A1 (es) 1985-02-16
ES529912A0 (es) 1985-02-16
DE3306060A1 (de) 1984-08-23
JPS59224687A (ja) 1984-12-17
ES8505409A1 (es) 1985-05-16

Similar Documents

Publication Publication Date Title
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
EP0260610A3 (en) Monoclonal antibodies against human tumour necrotic factor (tnf), and their use
IL71621A0 (en) Use of alpha factor sequences in yeast expression systems
EP0192001A3 (en) Papilloma virus probes and in vitro methods for the diagnosis of papilloma virus infections
GB2109684B (en) Serum thymic factor for use in the treatment of immuno deficiency
AU3227684A (en) Detection of antibodies in human serum
IL71017A (en) Hybrid cell lines,monoclonal antibodies prepared thereby and their use in the purification,diagnosis and detection of human interferon of type alpha
AU6032786A (en) Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
PT85567A (en) Monoclonal antibodies and peptides useful in treating and diagnosing hiv infections
AU4688785A (en) Monoclonal antibodies to glycoconjugates and use in cancer detection and treatment
EP0240344A3 (en) Monoclonal antibodies and their use
EP0146866A3 (en) Phenylsulfonephthaleinyl-beta-d-galactosides, methods for their preparation and their use in the determination of beta-d-galactosidase
GB8417338D0 (en) Human proteins antisera and test kits
IL70686A0 (en) Novel cell lines for use in the preparation of hybridoma cells
IT1189058B (it) Sedile in particolare per l'impiego in automobili,velivoli e abitazioni
GB2153364B (en) Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
EP0131627A4 (en) SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
EP0137258A3 (en) Zirconia-titania-silica tergels and their use as catalyst supports
IL84040A0 (en) Monoclonal antibodies against ifn-omega,their preparation and their use in the purification and detection of ifn-omega
JPS6471482A (en) Cell line and antiepiglycanin monoclonal antibody produced thereby
ZA843060B (en) Use of alpha factor sequences in yeast expression systems
IL73941A0 (en) Ultrasonic detector cell and system
GB8403707D0 (en) Exhaust-gas recirculation system
GB2082769B (en) Improvements in ultrasonic diagnosis systems
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis

Legal Events

Date Code Title Description
MM9K Patent not in force due to non-payment of renewal fees